Drivers and Trends Benefits Biologics Market to Grow at 8.25% CAGR, projected to Reach USD 412 billion in 2024

Drivers and Trends Benefits Biologics Market to Grow at 8.25% CAGR, projected to Reach USD 412 billion in 2024

Share this Post to earn Money ( Upto ₹100 per 1000 Views )


Drivers and Trends Benefits Biologics Market to Grow at 8.25% CAGR, projected to Reach USD 412 billion in 2024

According to MarkNtel Advisors who is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. Recently released a report on Biologics Market - Industry Trends and Forecast to 2030 and provides a comprehensive analysis of the current and future market conditions. The market research insights offered in this report enhance understanding of the market landscape, potential challenges, and strategies to establish a strong brand presence. With detailed market segmentation, in-depth analysis of key players, examination of consumer and supply chain trends, and exploration of new geographic markets, the insights presented in this report simplify the effective marketing of products and services.

Global Biologics Market Analysis and Size

The Global Biologics Market size is valued at USD 412 billion in 2024 and is projected to grow at a CAGR of around 8.25% during the forecast period, i.e., 2024-30.

Get a Free Sample PDF Copy of this Report to understand structure of the complete report @ https://www.marknteladvisors.com/query/request-sample/global-biologics-market.html

Some of the major players operating in the Biologics Market are Bristol-Myers Squibb, Pfizer, Sanofi, Janssen Biotech, Inc., Bayer AG, Merck & Co., Amgen Inc., Abbott GmbH, Novartis, AstraZeneca Plc, GlaxoSmithKline Biologicals, Moderna, Inc., Ferring Pharmaceuticals Inc., Aimmune Therapeutics, Inc., F. Hoffman La Roche, and Others.

Biologics Market Growth Driver:

Increasing Inclination Towards Gene Therapy & Cellular Therapy to Boost the Market Growth – Due to their ability to repair or substitute damaged tissues, gene and cellular treatments have experienced considerable growth in adoption over the historical years. Moreover, the rising investments in research & development of cell and gene therapies have been further bolstering their adoption, owing to the improved efficacy of new drugs. Additionally, there has been increased funding and investments for R&D purposes of cell and gene therapies by companies like Ori Biotech, AstraZeneca Plc, GlaxoSmithKline Biologicals, etc., for the launch of innovative products.

Thus, with enhanced investment, the process of pre-commercialization and market launch has been accelerated, which has been contributing to the market growth. Also, over the historical years, the approvals of these medicines have been accelerated by government organizations like the United States Food and Drug Administration (FDA), the European Medicines Agency (EMA), etc. Consequently, as approvals for cell and gene therapies would accelerate in the coming years, it would create an opportunity for their enhanced adoption in the coming years as well.

Browse More About This Research Report @ https://www.marknteladvisors.com/research-library/global-biologics-market.html

Market Segment and Geographical Analysis

By Therapeutic Application

  • Oncology- Market Size & Forecast 2019-2030, (USD Million)
  • Infectious Disease- Market Size & Forecast 2019-2030, (USD Million)
  • Autoimmune Disease- Market Size & Forecast 2019-2030, (USD Million)
  • Diabetes- Market Size & Forecast 2019-2030, (USD Million)
  • Cardiovascular Diseases- Market Size & Forecast 2019-2030, (USD Million)
  • Others (Inflammatory Bowel Diseases, Respiratory Disorders, Ophthalmic Disorders, etc.)- Market Size & Forecast 2019-2030, (USD Million)

By Drug Class

  • Recombinant Proteins- Market Size & Forecast 2019-2030, (USD Million)
    • Hormones- Market Size & Forecast 2019-2030, (USD Million)
    • Cytokines- Market Size & Forecast 2019-2030, (USD Million)
  • Monoclonal Antibodies- Market Size & Forecast 2019-2030, (USD Million)
  • Blood & Blood Components- Market Size & Forecast 2019-2030, (USD Million)
  • Cellular & Gene Therapy- Market Size & Forecast 2019-2030, (USD Million)
  • Vaccines- Market Size & Forecast 2019-2030, (USD Million)
  • Others- Market Size & Forecast 2019-2030, (USD Million)

By Source

  • Microbes- Market Size & Forecast 2019-2030, (USD Million)
  • Humans- Market Size & Forecast 2019-2030, (USD Million)
  • Others (Rodents, Plants, etc.)- Market Size & Forecast 2019-2030, (USD Million)

By Region

  • North America
  • South America
  • Europe
  • The Middle East & Africa
  • Asia-Pacific

Note - Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address.

Browse Trending Reports:

Note: If you require specific information not covered in the current report, we can provide it through customized option

Why choose Us?

MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.

For Media Inquiries, Please Contact:

Call: +1 628 895 8081 | +91 120 4278433

Emailsales@marknteladvisors.com

Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511

Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India